» Articles » PMID: 27761954

Novel Insights into Role of MiR-320a-VDAC1 Axis in Astrocyte-mediated Neuronal Damage in NeuroAIDS

Overview
Journal Glia
Specialty Neurology
Date 2016 Oct 21
PMID 27761954
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Astroglia are indispensable component of the tripartite synapse ensheathing innumerous soma and synapses. Its proximity to neurons aids the regulation of neuronal functions, health and survival through dynamic neuroglia crosstalk. Susceptibility of astrocyte to HIV-1 infection and subsequent latency culminates in compromised neuronal health. The viral protein HIV-1 transactivator of transcription (Tat) is neurotoxic. HIV-1 Tat is detected in brain of AIDS patients even in cases where viral load is non-detectable due to successful HAART therapy. Recently, we demonstrated that HIV-1 Tat triggers excess ATP release from astrocytes that causes neuronal death by activating purinergic receptor system. Using well-characterized model system of human primary astrocytes and neurons, we probed into the molecular mechanism for enhanced ATP release in HIV-1 Tat affected astrocytes. HIV-1 Tat modulated the miRNA machinery in astrocytes and perturbed the levels of voltage dependent anion channel 1 (VDAC1), a channel present in the outer mitochondrial membrane and plasma membrane that regulates extracellular ATP release. Our studies with autopsy tissue sections also showed concordantly dysregulated VDAC1 and miR-320a levels in HIV-1 patients suffering from mild cognitive impairment (MCI). We report a novel molecular cascade of miRNA-mediated ATP release through regulation of VDAC1. Downregulation of VDAC1 either with miR-320a mimic or VDAC1 siRNA in HIV-1 Tat-affected astroglia could rescue the neurons from glia-mediated indirect death. Our findings reveal a novel upstream therapeutic target that could be employed to thwart the astroglia-mediated neurotoxicity in HIV-1 neuropathogenesis. GLIA 2017;65:250-263.

Citing Articles

Analysis of Sigma-1 Receptor Antagonist BD1047 Effect on Upregulating Proteins in HIV-1-Infected Macrophages Exposed to Cocaine Using Quantitative Proteomics.

Velez-Lopez O, Carrasquillo-Carrion K, Cantres-Rosario Y, Machin-Martinez E, Alvarez-Rios M, Roche-Lima A Biomedicines. 2024; 12(9).

PMID: 39335448 PMC: 11428496. DOI: 10.3390/biomedicines12091934.


HIV-1 and methamphetamine co-treatment in primary human astrocytes: TAARgeting ER/UPR dysfunction.

Proulx J, Park I, Borgmann K NeuroImmune Pharm Ther. 2024; 3(2):139-154.

PMID: 39175523 PMC: 11338011. DOI: 10.1515/nipt-2023-0020.


Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes.

Yang R, Yang B, Liu W, Tan C, Chen H, Wang X J Neuroinflammation. 2023; 20(1):173.

PMID: 37481642 PMC: 10363317. DOI: 10.1186/s12974-023-02856-0.


Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.

Redensek Trampuz S, Vogrinc D, Goricar K, Dolzan V Front Mol Neurosci. 2023; 16:1123955.

PMID: 37008787 PMC: 10064073. DOI: 10.3389/fnmol.2023.1123955.


Intranasally administered human MSC-derived extracellular vesicles inhibit NLRP3-p38/MAPK signaling after TBI and prevent chronic brain dysfunction.

Kodali M, Madhu L, Reger R, Milutinovic B, Upadhya R, Gonzalez J Brain Behav Immun. 2022; 108:118-134.

PMID: 36427808 PMC: 9974012. DOI: 10.1016/j.bbi.2022.11.014.